Lee‐Hwa Tai

2.3k citations
48 papers · 1.7k indexed · h-index 20

Lee‐Hwa Tai

44 papers receiving 1.7k citations

Peers

Lee‐Hwa Tai
Comparison fields: 5 of 93
  • Immunology 932
  • Oncology 658
  • Psychiatry and Mental health 226
  • Biotechnology 86
  • Genetics 277
Replace Christiano Tanese de Souza with:
Christiano Tanese de Souza Canada
Andrew P. Makrigiannis Canada
Renée Lengagne France
Soyoung Oh United States
Joseph A. Westrich United States
Mar Cabeza-Cabrerizo United Kingdom
Tomasz Ahrends United States
Elizabeth W. Sorensen United States
Michelle N. Messmer United States
Cécile Chartier United States
Lee‐Hwa Tai relative to Christiano Tanese de Souza Canada Christiano Tanese de Souza's profile →
Citations per field
00.5×1.5×2.3×
Christiano Tanese de Souza · 1×
Citations per year

Countries citing papers authored by Lee‐Hwa Tai

Since Specialization
Citations

This map shows the geographic impact of Lee‐Hwa Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee‐Hwa Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee‐Hwa Tai more than expected).

Fields of papers citing papers by Lee‐Hwa Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee‐Hwa Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee‐Hwa Tai. The network helps show where Lee‐Hwa Tai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lee‐Hwa Tai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lee‐Hwa Tai Line = papers co-authored together Lee‐Hwa Tai links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 202312
4 20232
5 20239
6 20234
7 20231
8 20220
9 202211
10 201759
11 201661
12 201412
13 201426
14 201356
15 2012187
16 201256
17 201257
18 200849
19 200886
20 2006105

About Lee‐Hwa Tai

Lee‐Hwa Tai is a scholar working on Immunology, Biotechnology and Internal Medicine, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (20 papers), Virus-based gene therapy research (12 papers), Cancer, Stress, Anesthesia, and Immune Response (11 papers), Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (9 papers), Cancer Research and Treatments (7 papers), CAR-T cell therapy research (7 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Immunology (932 citations), Oncology (658 citations) and Psychiatry and Mental health (226 citations). Lee‐Hwa Tai has collaborated with scholars based in Canada, Saudi Arabia and China. Frequent co-authors include Andrew P. Makrigiannis, Rebecca C. Auer, John C. Bell, Christine Lawson, Christiano Tanese de Souza, Simon Bélanger, Samuel G. Rouleau, Almohanad A. Alkayyal, Jiqing Zhang and Caroline J. Breitbach. Their work appears in journals such as Nature, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026